Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors
about
ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndromeAlterations of Phosphodiesterases in Adrenocortical TumorsACTH-independent Cushing's syndrome with bilateral micronodular adrenal hyperplasia and ectopic adrenocortical adenoma.Cyclic AMP, protein kinase A, and phosphodiesterases: proceedings of an international workshopFrequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype.Phosphodiesterase 11A (PDE11A) genetic variants may increase susceptibility to prostatic cancer.Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma.Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes.p54nrb/NONO regulates cyclic AMP-dependent glucocorticoid production by modulating phosphodiesterase mRNA splicing and degradation.Phosphodiesterase sequence variants may predispose to prostate cancer.Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutationsIdentification of novel genetic variants in phosphodiesterase 8B (PDE8B), a cAMP-specific phosphodiesterase highly expressed in the adrenal cortex, in a cohort of patients with adrenal tumours.Protein kinase A defects and cortisol-producing adrenal tumorsRegulation of the adrenocortical stem cell niche: implications for diseasePhosphodiesterase 11A (PDE11A) gene defects in patients with acth-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumorsPhosphodiesterase function and endocrine cells: links to human disease and roles in tumor development and treatmentcAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse.New genes and/or molecular pathways associated with adrenal hyperplasias and related adrenocortical tumors.The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits.Genetic variation in phosphodiesterase (PDE) 7B in chronic lymphocytic leukemia: overview of genetic variants of cyclic nucleotide PDEs in human disease.Functional phosphodiesterase 11A mutations may modify the risk of familial and bilateral testicular germ cell tumors.Targeting cancer with phosphodiesterase inhibitors.Clinical and molecular genetics of the phosphodiesterases (PDEs).Genetic aspects of adrenocortical tumours and hyperplasias.A genetic and molecular update on adrenocortical causes of Cushing syndrome.E pluribus unum? The main protein kinase A catalytic subunit (PRKACA), a likely oncogene, and cortisol-producing tumors.A Role for Phosphodiesterase 11A (PDE11A) in the Formation of Social Memories and the Stabilization of Mood.Activating PRKACB somatic mutation in cortisol-producing adenomas.The Many Faces of Primary Aldosteronism and Cushing Syndrome: A Reflection of Adrenocortical Tumor Heterogeneity.
P2860
Q24310286-2E5B9DC6-B528-41C8-809F-8DBD07A84CF3Q28066278-F7F292E5-70D2-42EC-BE46-1C43E22449DBQ33586715-99F0E3B0-AF34-4053-A84C-52070D78B988Q34055579-FFEFF009-E591-49B9-BA5B-C99D619A337DQ34571810-16594158-5670-4C38-800E-A62B48FDC8A9Q34571859-C39BC28A-F637-4C06-BBA2-805F7F62F17CQ34765802-D328CEC2-C85E-4D4B-BA02-2AA082011A1BQ34810821-EF7DFFFA-BEDA-4F76-B487-9E2DC7ED1B57Q35106820-843A5A4D-1BEA-4323-8378-BCE43FF35E9BQ35165187-5C5B9C2C-8EDF-4E3B-AA65-D1429E017F11Q35843428-49928A1F-08FF-4EBF-A1B9-D49B5671DA14Q35869529-65039073-0036-49D0-94F5-7893D68A69C7Q35990225-55736256-F779-4EEC-84FB-C6A53C843FCDQ36030218-2C478C0F-4ADC-4741-A6F7-A1ACE3776DEBQ36288064-C227E2F3-21B6-4310-80FE-4ECC90B59A7FQ36361438-724B8257-8547-4BB4-A98D-A80BC30EE488Q36503940-0CD45150-7CCB-4F62-BC81-0D0683EBC6E6Q36763148-8DD18237-78DD-4CAF-9267-A20552D4D1EBQ37156654-26D0BECB-E867-4181-BC8F-3828971CB957Q37257579-E9A68C1E-1D27-44E1-ABA7-3791E7D741F0Q37323162-7AFDBBF4-BB87-4C2A-B64E-CB86A10F7160Q37325191-DAEB8F8B-C2A6-4690-8DDC-587DE875B93CQ37650389-34DCD04C-E585-40C0-88BE-B51F88ECC4D3Q37657841-712B9DD3-BF46-455D-AD8E-5F9238A67B04Q37999464-8E693CD8-F433-4546-9FE8-3CC1CBD04FE8Q38769185-15FB9799-016C-41C1-91B3-C5B1826FB293Q42547576-4E113BF9-76A2-41F4-B3B5-E26CB7812E97Q47147373-617AD0B5-708D-4FA1-8B21-3A8D85D4EFB8Q52579656-E2071194-C048-4F27-92DE-A083662C4CD3Q54981564-AA619930-191B-40F5-8769-0FAFF97B4CA0
P2860
Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors
@ast
Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors
@en
type
label
Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors
@ast
Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors
@en
prefLabel
Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors
@ast
Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors
@en
P2093
P2860
P50
P1476
Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors
@en
P2093
Amato Fratticci
Anelia Horvath
Fernande Rene-Corail
Frédérique Tissier
Joel Coste
Marie Laure Raffin-Sanson
Xavier Bertagna
P2860
P304
P356
10.1158/1078-0432.CCR-08-0106
P407
P577
2008-06-01T00:00:00Z